Comparison of Obturator Nerve Blockade and Neuromuscular Blockade

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 25, 2017

Primary Completion Date

September 19, 2019

Study Completion Date

September 19, 2019

Conditions
Cancer of Bladder
Interventions
DRUG

Obturator block

Subjects allocated to the obturator block group will be monitored for the incidence of block and procedure-related adverse events. In addition to clinical observation, a Nerve Integrity Monitor (Medtronic) will be used to detect adductor spasm using continuous electromyography. Electrodes will be placed on the thigh to objectively detect and record instances of adductor spasm. One hour after arrival to post-anaesthesia care unit (PACU) or when discharge criteria are met (whichever comes first), repeat dynamometer measurements and TUG tests will be performed. Patients will be called 24-48 hours post procedure to inquire about falls or evidence of nerve injury, as well as patient satisfaction.

DRUG

Neuromuscular block

Subjects allocated to the neuromuscular block group will be monitored for the incidence of block and procedure-related adverse events. In addition to clinical observation, a Nerve Integrity Monitor (Medtronic) will be used to detect adductor spasm using continuous electromyography. Electrodes will be placed on the thigh to objectively detect and record instances of adductor spasm. One hour after arrival to PACU or when discharge criteria are met (whichever comes first), repeat dynamometer measurements and TUG tests will be performed. Patients will be called 24-48 hours post procedure to inquire about falls or evidence of nerve injury, as well as patient satisfaction.

Trial Locations (1)

32608

Malcom Randall VA Medical Center, Gainesville

All Listed Sponsors
collaborator

US Department of Veterans Affairs

FED

lead

University of Florida

OTHER

NCT03063255 - Comparison of Obturator Nerve Blockade and Neuromuscular Blockade | Biotech Hunter | Biotech Hunter